Gene Therapy of Multiple Sclerosis Using Interferon β-Secreting Human Bone Marrow Mesenchymal Stem Cells

Interferon-beta (IFN-β), a well-established standard treatment for multiple sclerosis (MS), has proved to exhibit clinical efficacy. In this study, we first evaluated the therapeutic effects for MS using human bone marrow-derived mesenchymal stem cells (hBM-MSCs) as delivery vehicles with lesion-tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Chung Heon, Park, Kwang Ywel, Hou, Yun, Jeong, Chang Hyun, Kim, Seong Muk, Jeun, Sin-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654641/
https://www.ncbi.nlm.nih.gov/pubmed/23710456
http://dx.doi.org/10.1155/2013/696738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654641/
https://www.ncbi.nlm.nih.gov/pubmed/23710456
http://dx.doi.org/10.1155/2013/696738

Ejemplares similares